These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2906897)

  • 1. Bopindolol in the treatment of moderate hypertension: a dose-response study.
    Moleur P; Peyrieux JC; Luciani J; David D; Boissel JP
    Fundam Clin Pharmacol; 1988; 2(5):431-40. PubMed ID: 2906897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-finding study with bopindolol in arterial hypertension.
    Willimann P; Peter R; Siegenthaler H
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S25-9. PubMed ID: 2439814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension.
    Schiess W; Welzel D; Gugler R
    Eur J Clin Pharmacol; 1984; 27(5):529-34. PubMed ID: 6151506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effect of bopindolol: a multi-centre study.
    Török E; Szám I; Buday G; Kerkovits G; Farsang C; Hajtman B
    J Hum Hypertens; 1990 Aug; 4(4):458-60. PubMed ID: 1979635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive treatment with bopindolol alone or combined with a diuretic in general practice.
    Weidmann P; Bousquet JC
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S80-7. PubMed ID: 2439828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and long-term antihypertensive effect of bopindolol--a nonselective beta-adrenergic blocker with ISA.
    Andersson OK; Hedner T; Nyberg G
    Eur J Clin Pharmacol; 1985; 29(3):281-5. PubMed ID: 2866965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
    Colnago R; Meregalli M; Turri D; Nazzari M; Fiorella G; Guffanti EE; Mazzola C
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):347-52. PubMed ID: 2887520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta receptor block versus calcium antagonism. A comparative study of bopindolol and nifedipine with special regard to quality of life].
    Welzel D; Bräutigam M
    Arzneimittelforschung; 1989 Apr; 39(4):499-503. PubMed ID: 2568838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bopindolol on the circadian blood pressure profile in essential hypertension.
    Favre L; Adamec R; Boxho G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S60-3. PubMed ID: 2439823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bopindolol: long-term effects on blood pressure, renal function, plasma renin activity, and plasma aldosterone in mild-to-moderate essential hypertension.
    Shohat J; Modan M; Rosenfeld JB
    Fundam Clin Pharmacol; 1989; 3(1):53-8. PubMed ID: 2565862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and long-term antihypertensive effect of bopindolol once daily or once weekly.
    Andersson O; Hedner T; Nyberg G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S74-6. PubMed ID: 2439826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.
    Kirch W; Axthelm T
    Int J Clin Pharmacol Res; 1983; 3(2):89-93. PubMed ID: 6148312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The antihypertensive efficacy and tolerance of bopindolol (LT 31-200) in hypertensive patients].
    Honorato J; Galende I; Catalán M; Azanza JR
    Rev Med Univ Navarra; 1990; 34(2):90-4. PubMed ID: 1983366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIS (Multicentric Isradipine Study of antihypertensive therapy).
    Widimský J; Dzúrik R; Fetkovská N; Balazovjech I; Kvasnicka J; Lupínek Z; Mayer O; Pidrman V
    Cor Vasa; 1992; 34(1):4-14. PubMed ID: 1363224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bopindolol: Czechoslovak experience with a new beta blocker in the treatment of hypertension.
    Widimský J; Lefflerová K; Dvorák I; Fedelesová V; Lupínek Z; Mayer O; Pinterová E
    Am J Cardiol; 1991 Apr; 67(10):36B-42B. PubMed ID: 1673580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bopindolol in the treatment of hypertension: a double blind study comparing bopindolol and metoprolol.
    Lefflerová K; Lupínek Z; Widimský J; Lupínková Z; Uhlír O; Miklis P; Zeman K; Zicha J
    Cor Vasa; 1989; 31(5):387-93. PubMed ID: 2575480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive therapy with once-daily administration of terazosin, a new alpha 1-adrenergic-receptor blocker.
    Abraham PA; Halstenson CE; Matzke GR; Napier JL; Keane WF
    Pharmacotherapy; 1985; 5(5):285-9. PubMed ID: 2866492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the antihypertensive effects of bopindolol and metoprolol in the treatment of arterial hypertension].
    Bagatin J; Kuzmanić A; Rumboldt Z; Mirić D; Naranca M; Obad M; Pivac N; Polić S; Rakić D
    Med Pregl; 1990; 43(3-4):145-8. PubMed ID: 1978233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effect of isradipine on blood pressure at rest and during exercise.
    Dvorák I; Blaha M; Nĕmcová H
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):144S-146S. PubMed ID: 1673616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a new long-acting beta-blocker bopindolol (LT 31-200) on blood pressure, plasma catecholamines, renin and cholesterol in patients with arterial hypertension.
    van Brummelen P; Bühler FR; Amann FW; Bolli P
    Eur J Clin Pharmacol; 1982; 22(6):491-3. PubMed ID: 6127218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.